There was also a significant downregulation of the oncogene KRAS, the anti-inflammatory marker IL-10, and the liver-specific gene alpha-fetoprotein (AFP), also considered as an HCC biomarker (Fig. 4 A). The gene discussed is KRAS; the disease is hepatocellular carcinoma.